Dr. Katherine Matthay, MD

Dr. Katherine Matthay, MD

Professor Emeritus, UCSF School of Medicine

Doctor of Medicine, Perelman School of Medicine at the University of Pennsylvania

Dr. Katherine K. Matthay has 43 years of experience in the field of Pediatric Hematology-Oncology. She earned her BA in Chemistry from Bryn Mawr College and her MD from the Perelman School of Medicine at the University of Pennsylvania. After completing both an internship and residency in Pediatrics at the University of Colorado School of Medicine, she went on to complete a fellowship in Pediatric Hematology-Oncology at the UCSF Medical Center. Today, this expert is board-certified in Pediatrics and Pediatric Hematology-Oncology. Formerly, this expert served as the Leader of the Pediatric Malignancies Program at the UCSF Helen Diller Family Comprehensive Cancer Center and as the Medical Director of the Pediatric Day Treatment Center at the UCSF Medical Center. She was also the Director of the Pediatric Hematology-Oncology Fellowship and Chief of the Pediatric Hematology-Oncology Division at the UCSF Medical Center. She currently serves as a Professor (Recalled Faculty) and as a Professor Emeritus in the Department of Pediatrics at the UCSF School of Medicine, where she also holds the title of Mildred V. Strouss Endowed Chair in Translational Research in Pediatric Oncology. She is also the Chief of Pediatric Hematology-Oncology at the UCSF Benioff Children's Hospital San Francisco, where she also serves as an Attending Physician on the Pediatric Oncology Service and the Pediatric Bone Marrow Transplant Service. Moreover, she is also an Associate at the UCSF Brain Tumor Center.

k*********@****.edu

(415) ***-****

San Francisco, California

$499

Special offer

Get a FREE Demo of Dr. Katherine Matthay, MD's Radar Profile

Review this expert's litigation history, supporting legal docs, publications, professional background, and more.

LIVE DEMO

Get a FREE Demo of Dr. Katherine Matthay, MD's Radar Profile

Radar Metrics At A Glance

Expert Witness Activity

lock icon

Plaintiff Cases

lock icon

Defense Cases

lock icon

Expert Challenges

lock icon

Deposition Transcripts

lock icon

Publications

373

Media & News

248

Social Media Mentions

lock icon

Expert Institute operates independently and objectively as an expert witness data provider. Expert Institute does not employ, endorse, or have an affiliation with any expert witnesses for which data is provided.

Expert Witness Activity

Case Name

Role

Filed Date

Unlock Dr. Katherine Matthay, MD's full profile

Litigation Analytics

Retained By

Defense

Plaintiff

33%67%

Activity over time

0

25

50

75

100

2000

0

2002

0

2004

0

2006

0

2008

0

2010

0

Activity by state

Map of USA

Case Outcome

0

25

50

75

100

Publications

Radar found 373 records

Title

Type

Modulation of Radiation Biomarkers in a Randomized Phase II Study of 131I-MIBG With or Without Radiation Sensitizers for Relapsed or Refractory Neuroblastoma

Journal Article

Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results

Journal Article

Impact of diagnostic and end-of-induction Curie scores with tandem high-dose chemotherapy and autologous transplants for metastatic high-risk neuroblastoma: A report from the Children's Oncology Group

Journal Article

Radar monitors a wide array of publication sources, including links to abstracts.

Review book chapters, journal articles, research papers, trade publications, technical reports, conference proceedings, and more.

image

Media & News

Radar found 248 records

Title

Description

Research-Driven Efforts Push Neuroblastoma Care Forward

4 days ago ----- In 1986, pediatric hematologist - oncologist Katherine Matthay , MD, performed the first therapy of 131 I-metaiodobenzylguanidine ( 131 I-MIBG) in ...

Neuroblastoma Treatment (PDQ®)

Apr 30, 2024 ----- Matthay KK, Blaes F, Hero B, et al ... Lukens, Katherine K. Matthay , Robert P. Castleberry ... Jude Children's Research Hospital); Malcolm A ...

MIBG Combination Therapies Show Promise in ...

Jul 20, 2023 ----- Results were presented at the Advances in Neuroblastoma Research meeting ... Mosse, Katherine K. Matthay , Julie R. Park ... Children's Hospital Los ...

Radar scours thousands of media and news sources across the internet 24/7.

Access interviews, webinars, TV appearances, blog posts, columns, whitepapers, PDFs, profressional profiles, and more.

image

Education

Institution

Degree Type

Perelman School of Medicine at the University of Pennsylvania

Doctor of Medicine

Bryn Mawr College

Bachelor of Arts

Work History

Title

Employer

Professor Emeritus

UCSF School of Medicine

Mildred V. Strouss Endowed Chair

UCSF School of Medicine

Professor (Recalled Faculty)

UCSF School of Medicine

What to expect from a Radar profile

Access detailed litigation history and performance metrics.

Access your Radar profile through Expert iQ, our secure, cloud-based platform that hosts AI-driven insights.

Delivered in 3-5 days

Receive your profile swiftly, with Radar gathering intelligence from thousands of data points.

24/7 monitoring for 12 months

Stay informed with continuous monitoring and live alerts, ensuring your profile is always up-to-date.

bakground
Expert iQ logo
Expert Radar features